XP12B
XP12B Uses, Dosage, Side Effects, Food Interaction and all others data.
XP12B is being developed by Xanodyne Pharmaceuticals for the treatment of menorrhagia (heavy menstrual bleeding). It was granted Fast Track status for this indication by the FDA in November 2004.
Trade Name | XP12B |
Generic | XP12B |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Uses
Investigated for use/treatment in menstrual disorders.
Innovators Monograph
You find simplified version here XP12B